Overview

• GE HealthCare posted Q1 adjusted earnings per share of $1.01 on $4.78 billion in revenue, surpassing analysts' expectations of $0.92 EPS and $4.66 billion in revenue.
• The company revised its full-year adjusted EPS forecast to $3.90–$4.10, down from $4.61–$4.75, citing an $0.85-per-share impact from escalating global tariffs.
• Newly imposed tariffs include U.S.-China bilateral duties, levies on Mexico and Canada, and anticipated global reciprocal tariffs returning to pre-pause levels by July.
• The board approved a $1 billion stock buyback plan, signaling confidence in the company's long-term value despite trade-policy challenges.
• Shares rose over 6% in premarket trading following the earnings report and buyback announcement, reflecting positive market reception.